îæ€çŽ¢
îæ€çŽ¢
î
Vertex Pharmaceuticals Inc
VRTXîãŠã©ãããªã¹ãã«è¿œå
466.620USD
-0.170-0.04%
ååŒæé ïŒETïŒ15åé
ãã®æ ªäŸ¡
118.60Bæ䟡ç·é¡
27.44çŽè¿12ã¶æPER
åçäºæž¬
é貚: USD æŽæ°æå»: 2026-06-22Vertex Pharmaceuticals Incã®çŸåšã®åçäºæž¬ã¹ã³ã¢ã¯8.18ã§ãå»è¬åæ¥çã§ã¯157瀟äž50äœã§ãã ç®æšæ ªäŸ¡ã®å¹³åã¯492.50ã§ãæé«ã¯604.00ãæäœã¯330.00ã§ãã
ã¢ããªã¹ãè©äŸ¡
34
人ã®ã¢ããªã¹ãäºæ³ã«åºã¥ã
è²·ã
çŸåšã®è©äŸ¡
549.861
ç®æšæ ªäŸ¡
+21.75%
äžæäœå°
匷åè²·ã
è²·ã
äžç«
売ã
匷å売ã
åæ¥ä»ç€Ÿæ¯èŒ
175
åèš
6
äžå€®å€
8
å¹³å
äŒç€Ÿå
è©äŸ¡
ã¢ããªã¹ã
Vertex Pharmaceuticals Inc
VRTX
34
Biogen Inc
BIIB
38
Amgen Inc
AMGN
38
Eli Lilly and Co
LLY
35
AbbVie Inc
ABBV
34
Bristol-Myers Squibb Co
BMY
32
1
2
3
...
35
ãµããŒãã©ã€ã³ãšã¬ãžã¹ã¿ã³ã¹ã©ã€ã³
äŒç€Ÿããé¢é£ããŒã¿ããŸã é瀺ãããŠããŸããã
財åäºæž¬
EPS
åç
çŽå©ç
EBIT
äºæž¬å€
å®çžŸå€
å 責äºé ïŒã¢ããªã¹ãã®ã¬ãŒãã£ã³ã°ããã³ç®æšæ ªäŸ¡ã¯ãæ å ±æäŸã®ã¿ãç®çãšããŠLSEG Data & AnalyticsãæäŸãããã®ã§ãããæè³å©èšãæ§æãããã®ã§ã¯ãããŸããã
ãããã質å
Vertex Pharmaceuticals Inc ã®æ¬¡ã®ååæã®åçã¯ãããã§ãã?
îVertex Pharmaceuticals Inc ã®äºæ³åç㯠3.22B ã§ãã
Vertex Pharmaceuticals Inc ã®ç®æšæ ªäŸ¡ã¯ãããã§ãã?
îã¢ããªã¹ãã¯ãVertex Pharmaceuticals Inc ã®ç®æšæ ªäŸ¡ã USD 492.50 ãšäºæ³ããæé«äºæ³ã¯ USD 604.00ãæäœäºæ³ã¯ USD 330.00 ãšäºæ³ããŠããŸãã
Vertex Pharmaceuticals IncVRTX ã®æè¿ã® 1 æ ªåœããã®å©çã¯ã©ããªã£ãŠããŸãã?
îåžå Žäºæ³ã¯ USD 4.06 ã§ããããVertex Pharmaceuticals IncVRTX ã®åååæã®äžæ ªåœããå©ç (EPS) 㯠USD 4.70 ã§ããã次ã®ååæã® EPS 㯠USD 4.74 ãšäºæ³ãããŸãã
Vertex Pharmaceuticals Inc ã«å¯Ÿããã¢ããªã¹ãã®è©äŸ¡ã¯äœã§ãã?
î34 ã¢ããªã¹ãã«ãã Vertex Pharmaceuticals Inc æ ªã®è©äŸ¡ã«åºã¥ããšãã»ãšãã©ã®ã¢ããªã¹ã㯠買ã ã®ãã¬ã³ããæ¯æããŠããŸããä»ã®ã¢ããªã¹ãã®æèŠãèæ
®ããçµæãæçµçã« Vertex Pharmaceuticals Inc ã®æ ªäŸ¡ã¯ è²·ã ãšè©äŸ¡ãããŸããããã¯ååŒã«é¢ããã¢ããã€ã¹ã§ã¯ãªãããšã«æ³šæããŠãã ããããã¯ãç¬èªã®åæãè¡ãå¿
èŠããããŸãã
